Cargando…

Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients

Sodium glucose cotransporter 2 inhibitors (SGLT2i) are the first antidiabetic compounds that effectively reduce heart failure hospitalization and cardiovascular death in type 2 diabetics. Being explicitly designed to inhibit SGLT2 in the kidney, SGLT2i have lately been investigated for their off-tar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uthman, Laween, Baartscheer, Antonius, Schumacher, Cees A., Fiolet, Jan W. T., Kuschma, Marius C., Hollmann, Markus W., Coronel, Ruben, Weber, Nina C., Zuurbier, Coert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259641/ https://www.ncbi.nlm.nih.gov/pubmed/30519189 http://dx.doi.org/10.3389/fphys.2018.01575

Ejemplares similares

Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na(+)/H(+) exchanger 1: persistent inhibition under various experimental conditions
por: Zuurbier, Coert J, et al.
Publicado: (2021)

Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation
por: Uthman, Laween, et al.
Publicado: (2017)

Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells
por: Chen, Sha, et al.
Publicado: (2023)

The Driving Force of the Na(+)/Ca(2+)-Exchanger during Metabolic Inhibition
por: Baartscheer, Antonius, et al.
Publicado: (2011)

Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
por: Uthman, Laween, et al.
Publicado: (2020)

Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)/H(+) exchanger in rats and rabbits
por: Baartscheer, Antonius, et al.
Publicado: (2016)

Empagliflozin Decreases Lactate Generation in an NHE-1 Dependent Fashion and Increases α-Ketoglutarate Synthesis From Palmitate in Type II Diabetic Mouse Hearts
por: Zhang, Hong, et al.
Publicado: (2020)

Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus
por: Eroglu, Talip E, et al.
Publicado: (2022)

Direct cardiac effects of SGLT2 inhibitors
por: Chen, Sha, et al.
Publicado: (2022)

Amelioration of endothelial dysfunction by sodium glucose co‐transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection
por: Li, Xiaoling, et al.
Publicado: (2022)

Cyclophilin D ablation is associated with increased end-ischemic mitochondrial hexokinase activity
por: Nederlof, Rianne, et al.
Publicado: (2017)

Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart
por: Nederlof, Rianne, et al.
Publicado: (2017)

Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species
por: Li, Xiaoling, et al.
Publicado: (2021)

Dietary Omega-3 Polyunsaturated Fatty Acids Suppress NHE-1 Upregulation in a Rabbit Model of Volume- and Pressure-Overload
por: van Borren, Marcel M. G. J., et al.
Publicado: (2012)

Structure-function relationships in the sodium chloride cotransporter
por: Moreno, Erika, et al.
Publicado: (2023)

Sodium-Glucose Cotransporter 2 Inhibitors Potentially Prevent Atrial Fibrillation by Ameliorating Ion Handling and Mitochondrial Dysfunction
por: Peng, Xiaodong, et al.
Publicado: (2020)

Robert K. Crane—Na(+)-glucose cotransporter to cure?
por: Hamilton, Kirk L.
Publicado: (2013)

Modulation of the cardiac sodium/bicarbonate cotransporter by the renin angiotensin aldosterone system: pathophysiological consequences
por: De Giusti, Verónica C., et al.
Publicado: (2014)

Editorial: Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches
por: de Lucia, Claudio, et al.
Publicado: (2019)

Sodium-Glucose Cotransporter Inhibition Prevents Oxidative Stress in the Kidney of Diabetic Rats
por: Osorio, Horacio, et al.
Publicado: (2012)

Cardioprotective efficacy depends critically on pharmacological dose, duration of ischaemia, health status of animals and choice of anaesthetic regimen: a case study with folic acid
por: Zuurbier, Coert J, et al.
Publicado: (2014)

Activation of the Thiazide-Sensitive Sodium-Chloride Cotransporter by Beta3-Adrenoreceptor in the Distal Convoluted Tubule
por: Milano, Serena, et al.
Publicado: (2021)

Impact of sodium–glucose cotransporter 2 inhibitors on blood pressure
por: Reed, James W
Publicado: (2016)

Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?
por: Zuurbier, Coert J.
Publicado: (2020)

Reduced Sodium Current in the Lateral Ventricular Wall Induces Inferolateral J-Waves
por: Meijborg, Veronique M. F., et al.
Publicado: (2016)

Attenuated inflammatory profile following single and repeated handgrip exercise and remote ischemic preconditioning in patients with cerebral small vessel disease
por: Landman, Thijs R. J., et al.
Publicado: (2022)

NLRX1 Deletion Increases Ischemia-Reperfusion Damage and Activates Glucose Metabolism in Mouse Heart
por: Zhang, Hong, et al.
Publicado: (2020)

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
por: Tang, Jun, et al.
Publicado: (2022)

Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
por: Cavaiola, Tricia Santos, et al.
Publicado: (2018)

Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance
por: García-Ropero, Álvaro, et al.
Publicado: (2019)

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
por: Sano, Motoaki
Publicado: (2017)

Sodium-glucose cotransporter inhibitors: beyond glycaemic control
por: Vergara, Ander, et al.
Publicado: (2019)

Sodium–glucose cotransporters: Functional properties and pharmaceutical potential
por: Sano, Ryuhei, et al.
Publicado: (2020)

Renal outcomes with sodium-glucose cotransporters 2 inhibitors
por: Sun, Xiaoya, et al.
Publicado: (2022)

Renal glucose handling in diabetes and sodium glucose cotransporter 2 inhibition
por: Poudel, Resham Raj
Publicado: (2013)

Lack of Renal Tubular Glucocorticoid Receptor Decreases the Thiazide-Sensitive Na(+)/Cl(–) Cotransporter NCC and Transiently Affects Sodium Handling
por: Canonica, Jérémie, et al.
Publicado: (2019)

A randomized trial of remote ischemic preconditioning and control treatment for cardioprotection in sevoflurane-anesthetized CABG patients
por: Nederlof, Rianne, et al.
Publicado: (2017)

Pharmacological Cardioprotection against Ischemia Reperfusion Injury—The Search for a Clinical Effective Therapy
por: Wang, Qian, et al.
Publicado: (2023)

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin
por: Sanon, Vani P, et al.
Publicado: (2017)

Stem cells can form gap junctions with cardiac myocytes and exert pro-arrhythmic effects
por: Smit, Nicoline W., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_30m8rnhdt7umlfftp7jng8m46a